Cagrilintide is a long-acting analog of amylin, a hormone co-secreted with insulin by the pancreas. It has been developed to aid in weight management and glycemic control.
Actions of Cagrilintide:
- Appetite Suppression: Cagrilintide interacts with the central nervous system to reduce appetite, leading to decreased food intake.
- Delayed Gastric Emptying: It slows the rate at which the stomach empties, promoting a feeling of fullness and aiding in weight loss.
- Glucagon Secretion Modulation: Cagrilintide helps regulate glucagon secretion, contributing to better blood glucose c
Benefits of Cagrilintide:
- Weight Loss: Clinical trials have demonstrated that cagrilintide leads to significa
- Enhanced Glycemic Control: By improving insulin sensitivity and glycemic control, cagrilintide offers additional benefits for patients with type 2 diabetes.
- Combination Therapy Potential: When combined with GLP-1 receptor agonists like semaglutide, cagrilintide has shown enhanced effects on weight loss and glycemic control.
Overall, cagrilintide represents a promising advancement in the treatment of obesity and related metabolic disorders. Its unique mechanism of action offers a multifaceted approach to weight management and glycemic control.
Images
